CIK 0001680367 · Non-accelerated filer<br>Smaller reporting company
Shattuck Labs, Inc.
Sign in to watch- Ticker
- STTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812575858
- Phone
- 512-900-4690
- Business address
- 500 W. 5TH STREET, AUSTIN, TX, 78701
- Former names
- Shattuck Labs, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 90 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-26 | Golumbeski George Director | Grant or award · Stock Option (Right to Buy) | +40,258 | 40,258 | ||
| 2023-05-26 | Gibson Neil W Director | Grant or award · Stock Option (Right to Buy) | +40,258 | 40,258 | ||
| 2023-05-26 | Brownstein Carrie Director | Grant or award · Stock Option (Right to Buy) | +40,258 | 40,258 | ||
| 2023-05-26 | Brous Tyler Director | Grant or award · Stock Option (Right to Buy) | +40,258 | 40,258 | ||
| 2023-05-10 | Stout Stephen See Remarks | Grant or award | +15,900 | 30,875 | ||
| 2023-05-10 | Stout Stephen See Remarks | Grant or award · Stock Option (Right to Buy) | +31,800 | 31,800 | ||
| 2023-01-25 | Neill Andrew R Chief Financial Officer | Grant or award | +34,925 | 144,416 | ||
| 2023-01-25 | Neill Andrew R Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +69,850 | 69,850 | ||
| 2023-01-25 | Thomson Erin Ator General Counsel | Grant or award | +24,125 | 103,209 | ||
| 2023-01-25 | Thomson Erin Ator General Counsel | Grant or award · Stock Option (Right to Buy) | +48,250 | 48,250 |
Page 9 of 9 · 170 trades